Drug Hypersensitivity, Quality of Life
Conditions
Brief summary
We aim to validate the English (UK) translation of the DrHy-Q, and test its reliability in the UK population. This will facilitate for the subsequent economical evaluation of penicillin allergy delabelling. This research project is part of an MSc in Allergy undertaken by the principal applicant, Dr Patricia Romero, supervised through Imperial College London. Target population are patients with a drug allergy diagnosed by an Allergist prospectively at the Drug Allergy Clinic. Is the English version of the Drug Hypersensitivity Quality of Life Questionnaire suitable to be used in the UK population?
Interventions
OTHERQuestionnaires
No intervention
Sponsors
University Hospitals, Leicester
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* • Age \>18 years * Ability to read English and consent. * Confirmed diagnosis of a drug hypersensitivity reaction. * Written informed consent
Exclusion criteria
* • \< 18y/o. * Not able to read English. No mental capacity to consent or unwilling to consent. * Unconfirmed diagnosis of a drug hypersensitivity reaction.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Validation of the English version of the Drug Hypersensitivity Questionnaire | March 2023 May 2024 | Reliability and validity |
Countries
United Kingdom
Outcome results
None listed